The SQUEEZE project will help with the optimization of existing treatments for Rheumatoid Arthritis (RA) by exploring the latest developments in the field of biomarkers. We are focusing on the effect and safety of medicines, and analyse the best implementation science to enhance the therapeutic relationship between patients and doctors.
Welcome to the SQUEEZE project
Rheumatoid arthritis (RA) is a chronic immune-mediated condition with enormous socioeconomic and individual impact. Despite the availability of various treatment options, every patient seems to respond differently. Furthermore, the unsuccessful choice of the most suitable medication for a particular patient can lead to a scenario in which the patient consumes a drug that doesn’t align with their body’s response, ultimately aggravating the patient’s condition. We, at SQUEEZE, in synergy with other EU-wide activities, work to validate clinical, laboratory, molecular, digital, and behavioural biomarkers to help tailor the best treatment to the individual patient. Our aim is to improve the efficacy, safety, and satisfaction with existing therapies (by squeezing the most out of them!).
15 PARTNERS
11 COUNTRIES
€ 12.5 Mio
5 years
OUR CONSORTIUM
We are a team of leading academic centres with a first-class record in translational and clinical research, patient research partners and small and medium sized enterprises (SME) active in the field of innovative digital healthcare products, science communication, and project management.
SQUEEZE project
We aim to have a real impact on the life of people with rheumatoid arthritis
LATEST NEWS
SQUEEZE on the road: Engaging Rheumatology Communities across Europe
Scientific exchange with the clinical community is a cornerstone of the SQUEEZE project. Over the past year, consortium members have actively participated in national and regional rheumatology congresses across Europe, bringing SQUEEZE research [...]
The SQUEEZE team at the EULAR PARE 2025 Conference: Advancing Meaningful Patient Involvement
In November 2025, the SQUEEZE consortium once again took part in the Annual European EULAR Conference of PARE (People with Arthritis / Rheumatism in Europe), reaffirming its strong commitment to meaningful and sustained [...]
5th issue of our SQUEEZE newsletter published
We published the 5th issue of our SQUEEZE newsletter on our LinkedIn channel!! 🗞️💊 On a bi-annual basis, we will provide you with insights into our daily collaboration within our 13 partners [...]
Successful SQUEEZE Year 3 General Assembly meeting in Oslo, Norway
Our 5th General Assembly meeting was held from 13 to 15 October in Oslo, Norway together with over 50 scientists, clinicians and patient research partners from 11 European countries. The two-day event marked [...]
Strong Scientific Presence from the Vienna team: SQUEEZE at EWRR and IUIS 2025
Throughout the summer, the Vienna-based SQUEEZE team at the Medical University of Vienna further strengthened the project’s visibility within the European and international scientific community through active participation in two major conferences: the [...]
